Data from: Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis
Name:
Nwosu_T1DM_LDL_20180206_datase ...
Size:
9.134Mb
Format:
Microsoft Excel 2007
Description:
Dataset in Excel format
Name:
Nwosu_T1DM_LDL_20180206_dataset.csv
Size:
33.00Mb
Format:
Unknown
Description:
Dataset in csv format
Name:
Nwosu_T1DM_LDL_20180206_datase ...
Size:
27.17Kb
Format:
PDF
Description:
Nwosu T1DM LDL Dataset Legend
Authors
Nwosu, Benjamin U.Zhang, Bo
Ayyoub, Sanaa S.
Choi, Stephanie
Villalobos-Ortiz, Tony R.
Alonso, Laura C.
Barton, Bruce A.
UMass Chan Affiliations
Department of Quantitative Health SciencesDiabetes Division, Department of Medicine
Division of Endocrinology, Department of Pediatrics
Document Type
DatasetPublication Date
2018-02-06Keywords
type 1 diabetescholesterol
LDL
lipids
children
Endocrine System Diseases
Endocrinology, Diabetes, and Metabolism
Nutritional and Metabolic Diseases
Pediatrics
Metadata
Show full item recordAbstract
Manuscript abstract: Importance: Landmark studies showed that partial clinical remission in new-onset type 1 diabetes is associated with reduced prevalence of long-term complications, but early clinical indicators of this favorable outcome are poorly characterized. Aim: To determine if there were any differences in lipid parameters, especially LDL-cholesterol, between remitters and non-remitters 4 to 5 years after the diagnosis of type 1 diabetes after controlling for hemoglobin A1c, body mass index, and pubertal status. Subjects and Methods: A longitudinal retrospective cohort study of 123 subjects of mean age 11.9 ± 2.9 years, [male 11.7 ± 2.9 years, (n=55); female 12.0 ± 2.9 years, (n=68), p=0.60] with type 1 diabetes of 4-5 years duration. Anthropometric and biochemical data were collected at the 4th or 5th year after diagnosis in line with the American Diabetes Association recommendation to initiate screening for complications in children either at the beginning of puberty or 4-5 years after diagnosis. Puberty was defined by Tanner stages II-V. Partial clinical remission was defined by the gold-standard insulin-dose adjusted hemoglobin A1c (IDAA1c) of ≤9. Results: There were 44 (35.8%) remitters (age 13.0 ± 2.5y; male 52.3%). Both the total cholesterol and LDL-cholesterol were significantly lower in remitters compared to non-remitters: LDL-C: 78.8 ± 28.7 mg/dL vs. 91.6 ± 26.5 mg/dL, p=0.023; and total cholesterol: 151.5 ± 32.6 mg/dL vs. 167.0 ± 29.6 mg/dL, p=0.015. Other lipid fractions were similar between the groups. There were no differences between the groups for glycemic control, body mass index z score, thyroid function, celiac disease occurrence, or vitamin D status. Though a greater number of remitters were in puberty compared to non-remitters (86.4% vs. 60.8%, p=0.006), LDL-C concentration was similar in prepubertal remitters vs. non-remitters (p=0.93), but was significantly lower in remitters in puberty compared to non-remitters in puberty (p=0.018) after adjusting for age and duration of diabetes. Conclusions: Children with type 1 diabetes who underwent a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis regardless of their age, glycemic control, adiposity, or pubertal status. This early divergence in lipidemia may explain the dichotomy in the prevalence of long-term complication in type 1 diabetes between remitters and non-remitters. It also offers a pathway for targeted lipid monitoring in type 1 diabetes, by establishing non-remission as a non-modifiable risk factor for vascular complication in type 1 diabetes.DOI
10.13028/M2FT3KPermanent Link to this Item
http://hdl.handle.net/20.500.14038/43107Notes
Methodology is documented in manuscript.
Funding and Acknowledgements
The authors received no specific funding for this work.Related Resources
This dataset is the primary data source for the following published study: Nwosu BU, Zhang B, Ayyoub SS, Choi S, Villalobos-Ortiz TR, Alonso LC, Barton BA. Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis. PLoS One. 2018 May 16;13(5):e0196912. doi: 10.1371/journal.pone.0196912. eCollection 2018. PubMed PMID: 29768449; PubMed Central PMCID: PMC5955510.
Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/M2FT3K
Scopus Count
Collections
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/